Aldeyra Therapeutics, Inc (NASDAQ:ALDX) to Post Q3 2024 Earnings of ($0.15) Per Share, Leerink Partnrs Forecasts

Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Free Report) – Analysts at Leerink Partnrs issued their Q3 2024 earnings per share estimates for Aldeyra Therapeutics in a research report issued to clients and investors on Monday, March 11th. Leerink Partnrs analyst M. Goodman forecasts that the biotechnology company will post earnings of ($0.15) per share for the […]

Leave a Reply

Your email address will not be published.

Previous post Q2 2024 EPS Estimates for Avanos Medical, Inc. Decreased by Analyst (NYSE:AVNS)
Next post Q2 2024 EPS Estimates for Globus Medical, Inc. Boosted by Analyst (NYSE:GMED)